FCGR2A and neoplasm: The signature’s biological relevance was underscored by enrichment of myeloid regulators (e.g., FCGR2A, AUC = 0.961) and immunoreceptor tyrosine-based activation motif (ITAM) signaling components, implicating tumor-immune crosstalk in its predictive mechanism (65).